Assembly Biosciences, Inc. (ASMB) vs Autolus Therapeutics PLC Sponsored ADR (AUTL)
- Assembly Biosciences, Inc. ASMB 21.00 −7.77%
- Autolus Therapeutics PLC Sponsored ADR AUTL 1.66 −4.60%
Assembly Biosciences, Inc. and Autolus Therapeutics PLC Sponsored ADR are both Biotechnology companies. Assembly Biosciences, Inc. and Autolus Therapeutics PLC Sponsored ADR are of similar size ($481.8M and $479.1M). Autolus Therapeutics PLC Sponsored ADR has negative trailing earnings, so its P/E is not meaningful; Assembly Biosciences, Inc. trades at 22.3×. Autolus Therapeutics PLC Sponsored ADR grew revenue faster over the last twelve months: 193.3% against 125.1%. Assembly Biosciences, Inc. has the higher net margin (−0.06% vs −238.7%) and the higher return on invested capital (0.00% vs 0.00%). Across the 17 metrics below, Assembly Biosciences, Inc. leads on 13 and Autolus Therapeutics PLC Sponsored ADR on 4.
Valuation
Profitability
| Metric | ASMB | AUTL | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 15.66% | 65.16% |
| Operating margin | (11.75%) | (210.78%) | 0.00% |
| Net margin | (0.06%) | (238.66%) | 0.00% |
| Free cash flow margin | (51.53%) | (198.26%) | 0.00% |
| Return on equity | (0.03%) | (133.00%) | (56.66%) |
| Return on assets | (0.02%) | (46.15%) | (49.22%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack